2010 |
ragweed induced |
mice |
BM‐MSC |
i.v. |
BM MSC suppressed Th2‐driven allergic responses by TFG‐ β production |
84
|
2012 |
ovalbumin induced |
mice |
h iPSC vs. BM‐MSC |
i.v. |
iPSC‐MSC owned same therapeutic effect as BM MSC |
265
|
2015 |
house dust mite induced |
mice |
BM‐MSC |
i.v. |
Reduced eosinophilia, Th2 response and activated dendritic cells |
266
|
2015 |
ovalbumin induced |
mice |
BM‐MSC |
i.v. |
Reduced lymphocytes and eosinophils attraction, suppressed lung dendritic cell maturation and Th2 responses |
267
|
2016 |
ovalbumin induced |
mice |
BM‐MSC |
i.v. |
Reduced neutrophils and eosinophils recruitment, goblet cell hyperplasia and lung fibrosis |
268
|
2016 |
house dust mite induced |
mice |
BM‐MSC |
i.v. |
Expressed high levels of COXZ (MSCs), IL‐10 and TGF‐β (M2 macrophages) and low level of IL‐6 |
269
|
2017 |
house dust mite induced |
mice |
BM‐MSC |
i.t. |
Reduced inflammation, remodeling, and improved lung functions |
135
|
2017 |
ovalbumin induced |
mice |
hUCB‐MSC |
i.v. |
Reduced allergic inflammation which mediated by regulatory I cells |
270
|
2018 |
ovalbumin induced |
mice |
BM‐MSC vs. AT‐MSC |
i.t. |
Therapeutic efficiency only after BM‐MSC treated |
136
|
2018 |
ovalbumin induced |
rat |
hPD‐MSC |
i.v. |
Shifted from Notch‐1, ‐2 and jagged‐1 to Notch‐3, ‐4 and delta‐like ligand‐4 signaling |
271
|
2018 |
ovalbumin induced |
mice |
mASC‐ |
i.t. |
Alleviated airway inflammation, improved airway remodeling, and relieved airway hyper‐responsiveness with the restoration of Th1/Th2 cell balance |
16
|
2019 |
ovalbumin induced |
mice |
BM‐MSC |
i.v. |
Simvastatin and BMSCs affected serum IgE, lung IL‐13 and TGF‐β levels more than BMSC. Simvastatin increased BMSCs migration into the lung tissue |
272
|
2019 |
Th2‐mediated inflammation induced |
rats |
rBM‐MSC |
i.t. |
Ameliorated pathological changes presumably by targeting ICAM‐1 and VCAM‐1 |
13
|